Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)

Conditions:   Systemic Sclerosis;   Scleroderma Interventions:   Biological: Anifrolumab (blinded);   Drug: Placebo (blinded);   Biological: Anifrolumab (unblinded, open label) Sponsor:   AstraZeneca Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials